These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27337966)

  • 1. Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models.
    Rosa Durán M; Podolski-Renić A; Álvarez-Arenas A; Dinić J; Belmonte-Beitia J; Pešić M; Pérez-García VM
    Bull Math Biol; 2016 Jun; 78(6):1218-37. PubMed ID: 27337966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Transfer of Drug Resistance in Solid Tumors.
    Becker M; Levy D
    Bull Math Biol; 2017 Oct; 79(10):2394-2412. PubMed ID: 28852953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.
    Pasquier J; Magal P; Boulangé-Lecomte C; Webb G; Le Foll F
    Biol Direct; 2011 Jan; 6():5. PubMed ID: 21269489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1).
    Ambudkar SV; Sauna ZE; Gottesman MM; Szakacs G
    Trends Pharmacol Sci; 2005 Aug; 26(8):385-7. PubMed ID: 15978680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.
    Bebawy M; Combes V; Lee E; Jaiswal R; Gong J; Bonhoure A; Grau GE
    Leukemia; 2009 Sep; 23(9):1643-9. PubMed ID: 19369960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles and their emerging role in cancer multidrug resistance.
    Gong J; Jaiswal R; Mathys JM; Combes V; Grau GE; Bebawy M
    Cancer Treat Rev; 2012 May; 38(3):226-34. PubMed ID: 21757296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Model for Transfer of P-Glycoproteins in MCF-7 Breast Cancer Cell Line with Multiple Transfer Rules.
    Magal P; Noussair A; Pasquier J; Zongo P; Le Foll F
    Bull Math Biol; 2017 Sep; 79(9):2049-2067. PubMed ID: 28721472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
    Erić S; Kalinić M; Ilić K; Zloh M
    SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.
    Nanayakkara AK; Follit CA; Chen G; Williams NS; Vogel PD; Wise JG
    Sci Rep; 2018 Jan; 8(1):967. PubMed ID: 29343829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
    Shen H; Lee FY; Gan J
    J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect P-glycoprotein transfers in MCF7 breast cancer cells.
    Dyson J; Foll FL; Magal P; Noussair A; Pasquier J
    J Theor Biol; 2019 Jan; 461():239-253. PubMed ID: 30359573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
    Kowalski P; Surowiak P; Lage H
    Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
    Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis.
    Clarke R; Leonessa F; Trock B
    Semin Oncol; 2005 Dec; 32(6 Suppl 7):S9-15. PubMed ID: 16360717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of multidrug resistance of tumor cells.
    Szabó D; Keyzer H; Kaiser HE; Molnár J
    Anticancer Res; 2000; 20(6B):4261-74. PubMed ID: 11205256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticle-associated nucleic acids mediate trait dominance in cancer.
    Jaiswal R; Gong J; Sambasivam S; Combes V; Mathys JM; Davey R; Grau GE; Bebawy M
    FASEB J; 2012 Jan; 26(1):420-9. PubMed ID: 21965597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
    Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
    Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.